Human Proenkephalin A 119-159 (penKid) in Extracorporeal Therapies: Ex vivo Sieving Coefficient, Diffusive Clearance, and Hemoadsorption Kinetics
Authors:
- Anna LorenzinALAnna Lorenzin
- Massimo de CalMCMassimo de Cal
- Natascha PerinNPNatascha Perin
- Niccolò MorisiNMNiccolò Morisi
- Alessandra BrendolanABAlessandra Brendolan
- Paolo LentiniPLPaolo Lentini
- Monica ZanellaMZMonica Zanella
- Claudio RoncoCRClaudio Ronco
- 26 July 2024
- journal article
- research article
- Published by S. Karger AG in Blood Purification
- Vol. 53 (10) , 773-780
Abstract
Introduction: Enkephalins, endogenous opioid peptides, are involved in the regulation of renal function. One derived molecule, proenkephalin A, also known as penKid, has been demonstrated to be a reliable biomarker for kidney function and its plasma concentration correlates with measured glomerular filtration rate. penKid is used for prediction and diagnosis of AKI and need of renal replacement therapy (RRT). penKid has also been used to predict the successful weaning from RRT in patients with AKI. Whether the concentration of penKid is affected or not by RRT is a controversial point and there are no studies describing the kinetics of the molecule in such conditions. The low molecular weight (4.5 kDa) would imply free removal by the glomerulus and the dialysis membranes. During RRT, this reduction could not be detected in clinical practice due to the complex kinetics involving either low dialytic clearance or increased production in response to impaired kidney function. The aim of this study was to determine the sieving coefficient and the diffusive clearance of the penKid molecule in conditions of in vitro continuous veno-venous hemofiltration (CVVH) and continuous veno-venous hemodialysis (CVVHD), respectively, and also the penKid removal ratio in conditions of in vitro hemoadsorption (HA) using a synthetic microporous resin. Methods: Blood spiked with a lyophilized penKid peptide solved in 20 mm dipotassium phosphate and 6 mm disodium EDTA [pH 8] to reach target concentrations is used as testing solution. In each experiment, the blood batch was adjusted at a volume of 1,000 mL, maintained at 37°, and continuously stirred. Samples were collected from blood, ultrafiltrate, and spent dialysate at different times during the experiments. Sieving, clearance, and removal ratio were calculated. Results: Significant removal of penKid was observed in CVVH (sieving 1.04 ± 0.27), in CVVHD (clearance 23.08 ± 0.89), and in HA (removal ratio 76.1 ± 1% after 120 min). Conclusion: penKid is effectively removed by extracorporeal therapies. In presence of anuria, penKid generation kinetics can be calculated based on extracorporeal removal and volume variation. In steady state conditions, declining values may be the result of an initial renal function recovery and may suggest discontinuation and successful liberation from RRT.Keywords
This publication has 24 references indexed in Scilit:
- Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroupNature Reviews Nephrology, 2023
- Intradialytic kinetics of middle molecules during hemodialysis and hemodiafiltrationNephrology Dialysis Transplantation, 2018
- A New Series of Sorbent Devices for Multiple Clinical Purposes: Current Evidence and Future DirectionsBlood Purification, 2018
- Analytical performance of an immunoassay to measure proenkephalinClinical Biochemistry, 2018
- Haemodialysis membranesNature Reviews Nephrology, 2018
- Evaluation of urea and creatinine change during continuous renal replacement therapy: effect of blood flow rateCritical Care and Resuscitation, 2018
- Multidimensional Classification of Dialysis Membranes2017
- Proenkephalin expression and enkephalin release are widely observed in non-neuronal tissuesPeptides, 2008
- Proenkephalin A 119–159, a stable proenkephalin A precursor fragment identified in human circulationPeptides, 2006
- Hydrolysis of enkephalin by cultured human endothelial cells and by purified peptidyl dipeptidaseBiochemical Pharmacology, 1978